Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB

ホーム / Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB

Back to all Publications

Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB

2016 年 8 月 10 日

Author(s): Shubhada Shenai, Katharina Ronacher, Stefanus Malherbe, Kim Stanley, Magdalena Kriel, Jill Winter, Thomas Peppard, Charles Barry, Jing Wang, Lori Dodd, Laura Via, Clifton Barry, Gerhard Walzl, David Alland

Year: 2016 年 8 月 10 日

COVID-19 Therapeutic Considerations for Children and Pregnant Women

オンデマンド・ウェビナー

Accelerating Therapeutics for COVID-19

オンデマンド・ウェビナー

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

論文

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

論文

Powered by Translations.com GlobalLink OneLink Software